Marker Therapeutics Inc. (MRKR)
1.97
0.59 (42.75%)
At close: Mar 05, 2025, 2:20 PM
Marker Therapeutics Balance Sheet Statement
Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 | FY12 | FY11 | FY10 | FY09 | FY08 | FY07 | FY06 | FY05 | FY04 | FY03 | FY02 | FY01 | FY00 | FY99 |
Cash & Equivalents | 15.11M | 11.78M | 42.35M | 21.35M | 43.9M | 61.75M | 5.13M | 7.85M | 6.58M | 141.94K | 48.59K | 50.68K | 250.23K | 23.52K | 141.43K | 987.00 | 167.54K | 120.44K | 56.24K | 11.65K | 19.45K | 642.59K | 10K | 190K | 43.58K |
Short-Term Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Long-Term Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Long-Term Assets | n/a | -17.8M | n/a | -21.2M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 32.29K | n/a | n/a | n/a | n/a | n/a | n/a | 40.8K | n/a | n/a | 150K | n/a | n/a |
Receivables | 1.03M | 2.4M | 237.00 | 1M | 56.19K | 108.18K | n/a | n/a | n/a | n/a | n/a | 1.08K | 1.06K | 1.08K | 1.03K | 33.26K | 59.63K | n/a | n/a | n/a | n/a | n/a | n/a | 17K | 18.95K |
Inventory | -988.13K | n/a | n/a | -1M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 15K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -190K | 17.3K |
Other Current Assets | 1.98M | 2.44M | 3.63M | 2.06M | 3.05M | 283.43K | 51.15K | 70.15K | 68.8K | 82.5K | 28.44K | 52.46K | 56.63K | 700.00 | 214.5K | 9.52K | 35.31K | 33.73K | 27.08K | 467.00 | 1.03K | 6K | 11.56K | 68.46K | 15.36K |
Total Current Assets | 17.13M | 16.62M | 45.98M | 24.41M | 45.49M | 62M | 5.18M | 7.92M | 6.65M | 224.45K | 77.03K | 104.21K | 307.92K | 116.43K | 356.96K | 43.77K | 262.49K | 154.17K | 83.32K | 12.11K | 20.48K | 648.59K | 10K | 85.47K | 95.19K |
Property-Plant & Equipment | n/a | 17.8M | 22.15M | 21.2M | 873.17K | 148K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 9.14K | 16.62K | 166.00 | 6.54K | 35.27K | 72.72K | 112.84K | n/a | 35.32K | 53.1K |
Goodwill & Intangibles | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Total Long-Term Assets | n/a | 17.8M | 22.15M | 21.2M | 873.17K | 148K | n/a | n/a | n/a | n/a | n/a | n/a | 32.29K | n/a | n/a | 9.14K | 16.62K | 166.00 | 6.54K | 76.07K | 72.72K | 112.84K | 150K | 35.32K | 53.1K |
Total Assets | 17.13M | 34.42M | 68.14M | 45.61M | 46.36M | 62.14M | 5.18M | 7.92M | 6.65M | 224.45K | 77.03K | 104.21K | 340.21K | 116.43K | 356.96K | 52.91K | 279.11K | 154.34K | 89.86K | 88.19K | 93.21K | 761.43K | n/a | 120.79K | 148.28K |
Account Payables | 961K | 1.1M | 5.14M | 2.94M | 993K | 1.62M | 1.01M | 680K | 691.09K | 693.36K | 1.45M | 1.66M | 625.06K | 809.29K | 586.56K | n/a | 1.1M | 889.39K | 891.44K | 919.07K | 661.75K | 264.61K | 43.52K | 487.95K | 106.82K |
Deferred Revenue | n/a | 2.5M | 1.15M | 3.08M | 765K | n/a | 493K | 544.76K | n/a | 72.54K | 2.7M | 745.1K | 322.9K | 259.31K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Short-Term Debt | n/a | 577.2K | 1.24M | 777.58K | 408.26K | n/a | 5K | 5K | 53K | 52.94K | 6.05M | 1.45M | 1.11M | 919.81K | 338.02K | 819.96K | 496.58K | 1.67M | 542.67K | 477.1K | n/a | n/a | 190K | 194.79K | 104.4K |
Other Current Liabilities | 1.89M | 3.6M | 5.37M | 2.69M | 591.55K | 1.18M | 502.31K | 1.05M | 27.26M | 501.78K | 1.35M | 3.01M | 2.07M | 1.66M | 61.78K | 2.26M | 354.03K | 595.68K | 875.5K | 1.13M | 75.2K | 30.99K | n/a | n/a | 29.59K |
Total Current Liabilities | 3.07M | 7.78M | 12.9M | 6.4M | 1.99M | 2.8M | 1.52M | 1.74M | 28.01M | 1.25M | 8.85M | 5.77M | 3.8M | 3.39M | 986.35K | 3.08M | 1.95M | 3.15M | 2.31M | 2.53M | 736.95K | 295.6K | 173.03K | 682.74K | 240.81K |
Long-Term Debt | n/a | 7.04M | 22.5M | 23.74M | 560.49K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 48.9K |
Other Long-Term Liabilities | n/a | n/a | -11.25M | -11.87M | -280.25K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Total Long-Term Liabilities | n/a | 7.04M | 11.25M | 11.87M | 280.25K | 1.62M | 1.02M | 685.18K | 1.02M | 673.77K | 4.93M | 3.13M | 1.9M | 1.73M | 338.02K | 819.96K | 1.75M | 1.47M | 1.43M | 2.2M | 661.75K | 264.61K | 130.19K | 682.74K | 48.9K |
Total Liabilities | 3.07M | 14.82M | 24.15M | 18.27M | 2.27M | 2.8M | 1.52M | 1.74M | 28.01M | 1.25M | 8.85M | 5.77M | 3.8M | 3.39M | 986.35K | 3.08M | 1.95M | 3.15M | 2.31M | 2.53M | 736.95K | 295.6K | 173.03K | 682.74K | 289.71K |
Total Debt | n/a | 7.62M | 11.87M | 12.26M | 484.38K | n/a | 5K | 5K | 53K | 52.94K | 3.48M | 1.45M | 1.11M | 919.81K | 338.02K | 819.96K | 650.85K | 583.34K | 542.67K | 477.1K | n/a | n/a | 70K | 194.79K | 153.3K |
Common Stock | 8.89K | 8.41K | 83.08K | 50.73K | 45.73K | 45.44K | 10.62K | 8.42K | 70.55K | 20.32K | 144.67K | 76.4K | 52.07K | 40.26K | 38.36K | 24.15K | 23.5K | 29.17K | 29.17K | 20.1K | 18.81K | 15.85K | 37.76K | 14.35K | 13.19K |
Retained Earnings | -436.29M | -428.05M | -398.12M | -356.24M | -327.53M | -306.11M | -157.42M | -145.82M | -133.51M | -86.31M | -55.43M | -49.58M | -43.72M | -31.13M | -25.27M | -20.81M | -18.62M | -14.72M | -13.42M | -12.43M | -9.75M | -3.97M | -3.22M | -2.84M | -1.54M |
Comprehensive Income | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -58.33K | -61.65K | -60.53K | -60.9K | -59.73K | -59.73K | 7.67K | 368.56K | 791.54K | 631.41K | 687.16K | 801.08K | 15K | 57.9K | 4.75K |
Shareholders Equity | 14.05M | 19.6M | 43.99M | 27.34M | 44.09M | 59.34M | 3.66M | 6.18M | -21.36M | -1.02M | -8.77M | -5.67M | -3.46M | -3.27M | -629.39K | -3.02M | -1.67M | -3M | -2.22M | -2.44M | -643.75K | 465.83K | -173.03K | -561.95K | -141.42K |
Total Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |